Type 2 & other diabetes

Comparative Efficacy of Insulin Delivery Modalities on Glycaemic Control in Adults With Type 2 Diabetes: A Systematic Review and Network Meta‐Analysis

Diabetes Obes MetabPublished Systematic review and network meta-analysis of randomised trials

Authors' conclusion

HCL showed the most consistent glycaemic benefit, but body-weight and sparse safety evidence warrant caution.

Study context

Population
Adults with insulin-treated T2D
Participants
4,157 adults36 trials
Comparison
Insulin delivery modalities vs multiple daily injections (MDI)
Outcome
Change in HbA1c
Follow-up
Median 12 weeks
Methodological detailsparallel-group randomised trials, primary analysis excluding residual Other node, CINeMA certainty assessment, Most trials had risk-of-bias concerns; low-risk sensitivity analysis infeasible
  • Parallel-group randomised trials
  • Primary analysis excluding residual Other node
  • CINeMA certainty assessment
  • Most trials had risk-of-bias concerns; low-risk sensitivity analysis infeasible

Pooled result

As reported in the abstract

Each group vs MDIMD, % (95% CI)
HCL
−0.79(−1.33 to −0.25)
Continuous subcutaneous insulin infusion
−0.47(−0.74 to −0.20)

Further pooled results

OutcomeMD (percentage points) (95% CI)
TARHCLvs MDI−13.48 (−23.05 to −3.91)
OutcomeMD (U/day) (95% CI)
Insulin doseHCLvs MDI−15.69 (−31.33 to −0.06)
OutcomeMD (percentage points) (95% CI)
TIRHCL vs MDI+16.00 (+8.77 to +23.22)

Time in range (TIR)

Fully closed-loop yielded larger TIR/time above range (TAR) estimates, from one short trial only; hypothesis-generating

Insulin dose

Continuous subcutaneous insulin infusion also reduced insulin dose

Safety

OutcomeMD (kg) (95% CI)
Body weightHCL vs MDI+1.58 (+0.75 to +2.40)

Original publication

Comparative Efficacy of Insulin Delivery Modalities on Glycaemic Control in Adults With Type 2 Diabetes: A Systematic Review and Network Meta‐Analysis. Diabetes Obes Metab. Published 13 July 2026. doi:10.1111/dom.71104

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.